1. Renewing the call for reforms to medical device safety: the case of penumbra.;Kadakia;JAMA Intern Med,2022
2. The role of the Pharmaceuticals and Medical Devices Agency and healthcare professionals in post-marketing safety.;Mori;Clin J Gastroenterol,2014
3. Evolving acceptance and use of RWE for regulatory decision making on the benefit/risk assessment of a drug in Japan.;Nishioka;Clin Pharmacol Ther,2022
4. Pharmaceuticals and Medical Devices Agency. Penumbra system review report; 2011. Accessed December 6, 2021. https://www.pmda.go.jp/medical_devices/2011/M201100006/650099000_22300BZX00269000_A100_1.pdf
5. Japan Stroke Society, Japan Neurosurgical Society, Japanese Society for Neuroendovascular Therapy. The practice standards for use of the percutaneous transluminal cerebral thrombectomy devices; 2020. Accessed December 6, 2021. http://www.jsnet.website/sozai/info-shonin/100221noukessen_kijunn.pdf